We would like to keep you up to date with the latest news from MSP Channel Insights by sending you push notifications.
Digital Newsletter
Each week our editor Phil Alsop rounds up the most popular articles, videos and expert opinions. We compile this into a Digital Newsletter and send it straight to your inbox every week.
Digital Magazines
We'll let you know each time a new edition of MSP Channel Insights is released so that you're always kept up-to-date with the latest and greatest news and press releases.
Video Magazines
The MSP Channel Insights Video magazine contains the latest Zoom interviews with experts in the industry.
The EMA is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for human and veterinary use in the European Union. Serco supports the Agency by providing ICT Service Desk services to around 1000 employees, contractors and other stakeholders based at EMA's London HQ, plus a larger stakeholder community at various locations, mainly within the European Union, which includes personnel from Member State regulatory bodies, the pharmaceutical industry, healthcare professionals, patient and consumer organisations and the general public. Each year, the Service Desk handles around 60,000 calls in relation to the various ICT applications used by these individuals.
Serco provides first line support for a wide range of off-the-shelf applications, as well as over a 100 bespoke applications including EudraVigilance, a pharmacovigilance system serving over 18,000 users, and Eudralink, a secure messaging system with over 18,500 registered users. In addition, Serco is responsible for providing technical support for hardware (laptops, printers, smartphones etc.), as well as second line support for Microsoft Office applications and, for the first time under the new contract, Audio Visual (AV) equipment.
Michael Alner, Managing Director of Serco’s European business said: “We are delighted with the award of another four-year contract. Our team work hard to provide the European Medicines Agency with a high quality ICT service and we very much look forward to supporting them to be able to conduct their important work for a further four years.
